Tuesday, February 20, 2018 10:15 PM ET
Foundation Medicine (FMI) Insiders Make Significant Share Sales Extending the Trend of Last Quarter
In SEC filings today Foundation Medicine reported two insiders — Michael J Pellini, Director, and Troy Cox, Director and Officer — disposed of 26,336 shares in the company having a market value of approximately $1,778,448. There have been 8 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the disposition of 205,033 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 231,369 shares and have averaged 23,137 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at Foundation Medicine is above its 191-company peer group average. The Biotechnology & Medical Research peer group saw 151 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by Foundation Medicine insiders is lower than its peers. Within the peer group there were 11,494,769 shares purchased and 12,429,588 shares sold with company insiders disposing of 6,191 shares on average over this time period.
The data used in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* Michael J Pellini, Director, sold 17,324 shares
* Troy Cox, Director and Officer, sold 9,012 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.